

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.72561668 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 4.69810428 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.51130385 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.51130385 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.51130385 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.51130385 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.51130385 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.51130385 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.08811841 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.01517063 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01517063 |
| 12 | nuclear pore complex assembly (GO:0051292) | 4.00251246 |
| 13 | cellular extravasation (GO:0045123) | 4.00215292 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.96935796 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 3.96361000 |
| 16 | response to peptidoglycan (GO:0032494) | 3.87035469 |
| 17 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.76551672 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72080840 |
| 19 | nuclear pore organization (GO:0006999) | 3.59981541 |
| 20 | germinal center formation (GO:0002467) | 3.54643394 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.52315488 |
| 22 | detection of other organism (GO:0098543) | 3.49224242 |
| 23 | pinocytosis (GO:0006907) | 3.47738124 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37772140 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.34505952 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.33483757 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.33483757 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.30883615 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24323103 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.23413521 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20105744 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.17668398 |
| 33 | detection of bacterium (GO:0016045) | 3.13367980 |
| 34 | histone H3-K36 demethylation (GO:0070544) | 3.11152276 |
| 35 | natural killer cell mediated immunity (GO:0002228) | 3.09427053 |
| 36 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.09427053 |
| 37 | pore complex assembly (GO:0046931) | 3.08816303 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.07125342 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05490820 |
| 40 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04322038 |
| 41 | interkinetic nuclear migration (GO:0022027) | 3.03110266 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01071756 |
| 43 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.00194605 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99820849 |
| 45 | regulation of B cell differentiation (GO:0045577) | 2.98026942 |
| 46 | macrophage activation (GO:0042116) | 2.96873381 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 2.95956310 |
| 48 | regulation of leukocyte degranulation (GO:0043300) | 2.94851631 |
| 49 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94247043 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94156909 |
| 51 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90271075 |
| 52 | response to host immune response (GO:0052572) | 2.88736009 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88736009 |
| 54 | NLS-bearing protein import into nucleus (GO:0006607) | 2.87715128 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86864107 |
| 56 | positive thymic T cell selection (GO:0045059) | 2.80777045 |
| 57 | B cell proliferation (GO:0042100) | 2.79415966 |
| 58 | detection of biotic stimulus (GO:0009595) | 2.79010278 |
| 59 | positive regulation of histone deacetylation (GO:0031065) | 2.78347382 |
| 60 | heterochromatin organization (GO:0070828) | 2.76872515 |
| 61 | defense response to protozoan (GO:0042832) | 2.76254277 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.75013101 |
| 63 | regulation of platelet aggregation (GO:0090330) | 2.74376319 |
| 64 | microglial cell activation (GO:0001774) | 2.74270718 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74150031 |
| 66 | response to host (GO:0075136) | 2.73116880 |
| 67 | response to host defenses (GO:0052200) | 2.73116880 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.73116880 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 2.71226040 |
| 70 | morphogenesis of an endothelium (GO:0003159) | 2.68437016 |
| 71 | endothelial tube morphogenesis (GO:0061154) | 2.68437016 |
| 72 | growth hormone receptor signaling pathway (GO:0060396) | 2.67020950 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 2.66584217 |
| 74 | response to protozoan (GO:0001562) | 2.64868785 |
| 75 | neutrophil activation (GO:0042119) | 2.62478787 |
| 76 | mitotic chromosome condensation (GO:0007076) | 2.61986370 |
| 77 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.61300267 |
| 78 | B cell homeostasis (GO:0001782) | 2.60164477 |
| 79 | cellular response to vitamin D (GO:0071305) | 2.57854919 |
| 80 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56561054 |
| 81 | chromatin assembly (GO:0031497) | 2.54937757 |
| 82 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.54368679 |
| 83 | mature B cell differentiation (GO:0002335) | 2.53473278 |
| 84 | gene silencing by RNA (GO:0031047) | 2.53036054 |
| 85 | mature B cell differentiation involved in immune response (GO:0002313) | 2.52535272 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 2.52529090 |
| 87 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.52529090 |
| 88 | mitotic sister chromatid cohesion (GO:0007064) | 2.52255873 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51972196 |
| 90 | positive regulation of interferon-alpha production (GO:0032727) | 2.51836586 |
| 91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.50824455 |
| 92 | granulocyte activation (GO:0036230) | 2.50090586 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.49582026 |
| 94 | mitotic nuclear envelope disassembly (GO:0007077) | 2.49178241 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48632136 |
| 96 | B cell mediated immunity (GO:0019724) | 2.48470750 |
| 97 | negative regulation of cell killing (GO:0031342) | 2.48136012 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.48136012 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 2.47758905 |
| 100 | natural killer cell differentiation (GO:0001779) | 2.46834031 |
| 101 | protein localization to chromosome, centromeric region (GO:0071459) | 2.46460920 |
| 102 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.46099317 |
| 103 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.46099317 |
| 104 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.46099317 |
| 105 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45931677 |
| 106 | cellular hyperosmotic response (GO:0071474) | 2.45703725 |
| 107 | mRNA stabilization (GO:0048255) | 2.45000105 |
| 108 | RNA stabilization (GO:0043489) | 2.45000105 |
| 109 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.44893529 |
| 110 | stress fiber assembly (GO:0043149) | 2.44766626 |
| 111 | negative regulation of myotube differentiation (GO:0010832) | 2.44571370 |
| 112 | neutrophil mediated immunity (GO:0002446) | 2.44480889 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.44251339 |
| 114 | dosage compensation (GO:0007549) | 2.44171323 |
| 115 | respiratory burst (GO:0045730) | 2.43193887 |
| 116 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43129616 |
| 117 | mannose metabolic process (GO:0006013) | 2.42563367 |
| 118 | negative thymic T cell selection (GO:0045060) | 2.41982828 |
| 119 | protein localization to kinetochore (GO:0034501) | 2.41696794 |
| 120 | negative regulation of T cell mediated immunity (GO:0002710) | 2.41584128 |
| 121 | regulation of histone H3-K9 methylation (GO:0051570) | 2.40268423 |
| 122 | nuclear envelope disassembly (GO:0051081) | 2.39372845 |
| 123 | membrane disassembly (GO:0030397) | 2.39372845 |
| 124 | regulation of interferon-alpha production (GO:0032647) | 2.39245545 |
| 125 | T cell migration (GO:0072678) | 2.38765673 |
| 126 | piRNA metabolic process (GO:0034587) | 2.38693573 |
| 127 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.38692226 |
| 128 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38514743 |
| 129 | negative regulation of histone methylation (GO:0031061) | 2.38265676 |
| 130 | response to type I interferon (GO:0034340) | 2.37922522 |
| 131 | I-kappaB phosphorylation (GO:0007252) | 2.37598876 |
| 132 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37414524 |
| 133 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37414524 |
| 134 | pre-miRNA processing (GO:0031054) | 2.36897734 |
| 135 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.36681280 |
| 136 | regulation of RIG-I signaling pathway (GO:0039535) | 2.33716341 |
| 137 | thymic T cell selection (GO:0045061) | 2.33515843 |
| 138 | regulation of sister chromatid cohesion (GO:0007063) | 2.33214959 |
| 139 | regulation of necroptotic process (GO:0060544) | 2.31401696 |
| 140 | cellular response to type I interferon (GO:0071357) | 2.30942623 |
| 141 | type I interferon signaling pathway (GO:0060337) | 2.30942623 |
| 142 | negative T cell selection (GO:0043383) | 2.29435656 |
| 143 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.28551111 |
| 144 | synaptonemal complex assembly (GO:0007130) | 2.27374848 |
| 145 | peptidyl-lysine dimethylation (GO:0018027) | 2.24949259 |
| 146 | cell adhesion mediated by integrin (GO:0033627) | 2.24465551 |
| 147 | regulation of protein polyubiquitination (GO:1902914) | 2.24191874 |
| 148 | T cell selection (GO:0045058) | 2.23422310 |
| 149 | striated muscle atrophy (GO:0014891) | 2.21806593 |
| 150 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.21524172 |
| 151 | cellular response to growth hormone stimulus (GO:0071378) | 2.20332640 |
| 152 | immunoglobulin mediated immune response (GO:0016064) | 2.20079500 |
| 153 | cellular response to interferon-alpha (GO:0035457) | 2.19939888 |
| 154 | interferon-gamma secretion (GO:0072643) | 2.19910759 |
| 155 | positive regulation of protein deacetylation (GO:0090312) | 2.19766467 |
| 156 | corticosteroid receptor signaling pathway (GO:0031958) | 2.16348410 |
| 157 | hepatocyte apoptotic process (GO:0097284) | 2.16159357 |
| 158 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.15216568 |
| 159 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.15209516 |
| 160 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.14594232 |
| 161 | myeloid dendritic cell differentiation (GO:0043011) | 2.12928648 |
| 162 | positive regulation of nuclease activity (GO:0032075) | 2.12213075 |
| 163 | positive regulation of p38MAPK cascade (GO:1900745) | 2.11678978 |
| 164 | gene silencing (GO:0016458) | 2.11572763 |
| 165 | regulation of response to interferon-gamma (GO:0060330) | 2.09461211 |
| 166 | regulation of integrin activation (GO:0033623) | 2.07228982 |
| 167 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.07126601 |
| 168 | regulation of T cell tolerance induction (GO:0002664) | 2.06963760 |
| 169 | positive regulation of interferon-beta production (GO:0032728) | 2.06483306 |
| 170 | regulation of RNA export from nucleus (GO:0046831) | 2.06433671 |
| 171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.05681167 |
| 172 | synaptonemal complex organization (GO:0070193) | 2.05355455 |
| 173 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.04741756 |
| 174 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.04735120 |
| 175 | neutrophil activation involved in immune response (GO:0002283) | 2.04687919 |
| 176 | regulation of nuclease activity (GO:0032069) | 2.03378716 |
| 177 | positive regulation of interleukin-12 production (GO:0032735) | 2.02904464 |
| 178 | chromosome condensation (GO:0030261) | 2.02299324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.42145037 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.34956256 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77163172 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.71304494 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.59788043 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.37626136 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.13908365 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.80676917 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.77983222 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77648484 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.74754758 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51889429 |
| 13 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.51224730 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42706952 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39611815 |
| 16 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.27920325 |
| 17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27889706 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.18470134 |
| 19 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11322359 |
| 20 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04423621 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.03016348 |
| 22 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97790447 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95940107 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.94183843 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 1.89629111 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86605999 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85071604 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.82286323 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.81912262 |
| 30 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78447133 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78300043 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76127819 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75782212 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74967439 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73195328 |
| 36 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72853261 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70796992 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68564705 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68216864 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62603555 |
| 41 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57143725 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56524554 |
| 43 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56165751 |
| 44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53258719 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48222490 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47960905 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.47574669 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45924493 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45351401 |
| 50 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44296422 |
| 51 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40221215 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39909414 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38370676 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38308855 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34018100 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33102894 |
| 57 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32515388 |
| 58 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31085464 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30154463 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29982024 |
| 61 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29532308 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28597052 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27630699 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23739048 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22812009 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20628111 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18747661 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18747661 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17413133 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17265282 |
| 71 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.16434790 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16022676 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13829869 |
| 74 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12248748 |
| 75 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12062444 |
| 76 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11931590 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11261225 |
| 78 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.07570798 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07525869 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06935526 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05819354 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 1.05766857 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05564727 |
| 84 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04567153 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03505022 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03238079 |
| 87 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02691030 |
| 88 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.02629233 |
| 89 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02098024 |
| 90 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01978932 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01898891 |
| 92 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01127144 |
| 93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00828622 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00647974 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00121893 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00121893 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99925200 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99281153 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99260712 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98961628 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98925214 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98413700 |
| 103 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97634999 |
| 104 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97573000 |
| 105 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96825030 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96655928 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96175004 |
| 108 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96088947 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95919711 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95025175 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93717566 |
| 112 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93602417 |
| 113 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92109880 |
| 114 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92018178 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91915533 |
| 116 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90836774 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90501890 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90356371 |
| 119 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90236229 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90203303 |
| 121 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89714333 |
| 122 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88966627 |
| 123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88718154 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88308466 |
| 125 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87479116 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86762814 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86573000 |
| 128 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86271684 |
| 129 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85135247 |
| 130 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.85058170 |
| 131 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84969699 |
| 132 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84032115 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83892055 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83733333 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80418702 |
| 136 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.78831637 |
| 137 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.78831637 |
| 138 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.78831637 |
| 139 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77551960 |
| 140 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76342218 |
| 141 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76078604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 2.82883726 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 2.75738065 |
| 3 | MP0005451_abnormal_body_composition | 2.52659581 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.50387737 |
| 5 | MP0003724_increased_susceptibility_to | 2.47545924 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.46245067 |
| 7 | MP0000685_abnormal_immune_system | 2.40156541 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.38046050 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.17182039 |
| 10 | MP0010307_abnormal_tumor_latency | 2.12444836 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.09648804 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.07694951 |
| 13 | MP0009278_abnormal_bone_marrow | 2.07141114 |
| 14 | MP0003303_peritoneal_inflammation | 2.01097707 |
| 15 | MP0003828_pulmonary_edema | 1.99445121 |
| 16 | MP0003566_abnormal_cell_adhesion | 1.94473790 |
| 17 | MP0003646_muscle_fatigue | 1.93257876 |
| 18 | MP0005387_immune_system_phenotype | 1.92223197 |
| 19 | MP0001790_abnormal_immune_system | 1.92223197 |
| 20 | MP0005464_abnormal_platelet_physiology | 1.89692622 |
| 21 | MP0006054_spinal_hemorrhage | 1.82080729 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 1.79727189 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.77848614 |
| 24 | MP0003436_decreased_susceptibility_to | 1.77389686 |
| 25 | MP0004510_myositis | 1.75539014 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.70006818 |
| 27 | MP0001800_abnormal_humoral_immune | 1.68583119 |
| 28 | MP0002006_tumorigenesis | 1.67822009 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.63336815 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.61027080 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.57733270 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.56374820 |
| 33 | MP0002254_reproductive_system_inflammat | 1.52676325 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.50029777 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.48997569 |
| 36 | MP0000733_abnormal_muscle_development | 1.47332818 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.46435103 |
| 38 | MP0003091_abnormal_cell_migration | 1.42446162 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.38778686 |
| 40 | MP0002398_abnormal_bone_marrow | 1.38567560 |
| 41 | MP0002723_abnormal_immune_serum | 1.38525462 |
| 42 | MP0008057_abnormal_DNA_replication | 1.38051066 |
| 43 | MP0008260_abnormal_autophagy | 1.36151533 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.35686464 |
| 45 | MP0001819_abnormal_immune_cell | 1.35503528 |
| 46 | MP0003077_abnormal_cell_cycle | 1.35147500 |
| 47 | MP0004130_abnormal_muscle_cell | 1.34903982 |
| 48 | MP0005666_abnormal_adipose_tissue | 1.34692982 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.34283588 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.30438031 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.29597935 |
| 52 | MP0004947_skin_inflammation | 1.26603574 |
| 53 | MP0003448_altered_tumor_morphology | 1.25309324 |
| 54 | MP0008007_abnormal_cellular_replicative | 1.25200740 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.24010666 |
| 56 | MP0005671_abnormal_response_to | 1.23656960 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.22469046 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.20345894 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.20345894 |
| 60 | MP0003693_abnormal_embryo_hatching | 1.19887317 |
| 61 | MP0000858_altered_metastatic_potential | 1.19793818 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.19389340 |
| 63 | MP0000716_abnormal_immune_system | 1.19059240 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.18259107 |
| 65 | MP0009785_altered_susceptibility_to | 1.18165236 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.17862868 |
| 67 | MP0010094_abnormal_chromosome_stability | 1.17846564 |
| 68 | MP0005023_abnormal_wound_healing | 1.17788256 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.15735033 |
| 70 | MP0003111_abnormal_nucleus_morphology | 1.15492915 |
| 71 | MP0002405_respiratory_system_inflammati | 1.12106547 |
| 72 | MP0005025_abnormal_response_to | 1.09972693 |
| 73 | MP0003045_fibrosis | 1.09692785 |
| 74 | MP0004233_abnormal_muscle_weight | 1.07379566 |
| 75 | MP0002419_abnormal_innate_immunity | 1.07221028 |
| 76 | MP0002722_abnormal_immune_system | 1.07161637 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.05827363 |
| 78 | MP0001730_embryonic_growth_arrest | 1.05436742 |
| 79 | MP0000689_abnormal_spleen_morphology | 1.05080691 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 1.04459449 |
| 81 | MP0002009_preneoplasia | 1.02933852 |
| 82 | MP0002933_joint_inflammation | 1.02642178 |
| 83 | MP0002429_abnormal_blood_cell | 1.02516906 |
| 84 | MP0003283_abnormal_digestive_organ | 1.02516671 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.02182192 |
| 86 | MP0000350_abnormal_cell_proliferation | 1.02098146 |
| 87 | MP0002928_abnormal_bile_duct | 1.02072951 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.01236909 |
| 89 | MP0005310_abnormal_salivary_gland | 1.00928622 |
| 90 | MP0010368_abnormal_lymphatic_system | 1.00091611 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.00025520 |
| 92 | MP0001915_intracranial_hemorrhage | 0.99915973 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.99548099 |
| 94 | MP0005670_abnormal_white_adipose | 0.98346606 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.97910801 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.97124323 |
| 97 | MP0002086_abnormal_extraembryonic_tissu | 0.97047672 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.96190819 |
| 99 | MP0008004_abnormal_stomach_pH | 0.95597775 |
| 100 | MP0000490_abnormal_crypts_of | 0.94195340 |
| 101 | MP0010630_abnormal_cardiac_muscle | 0.93980309 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.93441734 |
| 103 | MP0001873_stomach_inflammation | 0.92146326 |
| 104 | MP0003984_embryonic_growth_retardation | 0.92060126 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92045920 |
| 106 | MP0002088_abnormal_embryonic_growth/wei | 0.90969998 |
| 107 | MP0004087_abnormal_muscle_fiber | 0.90842316 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.89635917 |
| 109 | MP0008469_abnormal_protein_level | 0.89203944 |
| 110 | MP0001851_eye_inflammation | 0.87669888 |
| 111 | MP0001853_heart_inflammation | 0.86577519 |
| 112 | MP0000371_diluted_coat_color | 0.86504459 |
| 113 | MP0009840_abnormal_foam_cell | 0.85830710 |
| 114 | MP0005380_embryogenesis_phenotype | 0.85784367 |
| 115 | MP0001672_abnormal_embryogenesis/_devel | 0.85784367 |
| 116 | MP0003690_abnormal_glial_cell | 0.85765746 |
| 117 | MP0004197_abnormal_fetal_growth/weight/ | 0.85263067 |
| 118 | MP0005621_abnormal_cell_physiology | 0.85178175 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.84337425 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.83214563 |
| 121 | MP0002019_abnormal_tumor_incidence | 0.82289321 |
| 122 | MP0001958_emphysema | 0.81557011 |
| 123 | MP0006082_CNS_inflammation | 0.81213632 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.80464549 |
| 125 | MP0001697_abnormal_embryo_size | 0.80443821 |
| 126 | MP0001879_abnormal_lymphatic_vessel | 0.79686903 |
| 127 | MP0000343_altered_response_to | 0.79226067 |
| 128 | MP0008961_abnormal_basal_metabolism | 0.79199692 |
| 129 | MP0005410_abnormal_fertilization | 0.78265389 |
| 130 | MP0009764_decreased_sensitivity_to | 0.77979391 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.77851526 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.77562239 |
| 133 | MP0002084_abnormal_developmental_patter | 0.77514626 |
| 134 | MP0005409_darkened_coat_color | 0.77457750 |
| 135 | MP0000249_abnormal_blood_vessel | 0.75236240 |
| 136 | MP0004484_altered_response_of | 0.74581649 |
| 137 | MP0000604_amyloidosis | 0.73943177 |
| 138 | MP0002168_other_aberrant_phenotype | 0.73128939 |
| 139 | MP0006138_congestive_heart_failure | 0.73106722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 3.70276096 |
| 2 | Spontaneous hematomas (HP:0007420) | 3.41899327 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.39719805 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.33432711 |
| 5 | Agammaglobulinemia (HP:0004432) | 3.16204007 |
| 6 | Nasal polyposis (HP:0100582) | 3.14761864 |
| 7 | Meningitis (HP:0001287) | 3.14321263 |
| 8 | Increased density of long bones (HP:0006392) | 3.03496860 |
| 9 | Cervical subluxation (HP:0003308) | 2.94708176 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 2.92198017 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 2.91525534 |
| 12 | Subacute progressive viral hepatitis (HP:0006572) | 2.86406412 |
| 13 | Cerebral aneurysm (HP:0004944) | 2.82140240 |
| 14 | Hematochezia (HP:0002573) | 2.81549266 |
| 15 | Gingivitis (HP:0000230) | 2.80170788 |
| 16 | Recurrent bronchitis (HP:0002837) | 2.75026131 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 2.74985518 |
| 18 | Aortic aneurysm (HP:0004942) | 2.72724536 |
| 19 | Optic neuritis (HP:0100653) | 2.71706660 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 2.71706660 |
| 21 | Absent frontal sinuses (HP:0002688) | 2.64933672 |
| 22 | Ulnar deviation of the wrist (HP:0003049) | 2.59484762 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58613213 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 2.55602189 |
| 25 | Recurrent skin infections (HP:0001581) | 2.51825624 |
| 26 | Metaphyseal cupping (HP:0003021) | 2.50402286 |
| 27 | Dysmetric saccades (HP:0000641) | 2.47369144 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 2.45691347 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.39837145 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.39837145 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.37654433 |
| 32 | Recurrent viral infections (HP:0004429) | 2.32139675 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.31944344 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30866420 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30866420 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30866420 |
| 37 | Subaortic stenosis (HP:0001682) | 2.29476686 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29476686 |
| 39 | Stomatitis (HP:0010280) | 2.27575019 |
| 40 | Malnutrition (HP:0004395) | 2.25115734 |
| 41 | Bronchitis (HP:0012387) | 2.23592633 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.22974516 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.22387113 |
| 44 | Persistence of primary teeth (HP:0006335) | 2.21440615 |
| 45 | Muscle fiber splitting (HP:0003555) | 2.20065483 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.17961602 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16056597 |
| 48 | Obstructive lung disease (HP:0006536) | 2.16056597 |
| 49 | Thin bony cortex (HP:0002753) | 2.15880544 |
| 50 | Difficulty running (HP:0009046) | 2.15527326 |
| 51 | Thrombocytosis (HP:0001894) | 2.14534414 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.13749416 |
| 53 | Hemoptysis (HP:0002105) | 2.13423654 |
| 54 | Abnormality of the calcaneus (HP:0008364) | 2.13362321 |
| 55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12853172 |
| 56 | Recurrent pneumonia (HP:0006532) | 2.12815612 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.12479766 |
| 58 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.09681200 |
| 59 | High pitched voice (HP:0001620) | 2.08330458 |
| 60 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06953144 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.06386156 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.06122381 |
| 63 | Nemaline bodies (HP:0003798) | 2.05522728 |
| 64 | Muscle fiber inclusion bodies (HP:0100299) | 2.04489856 |
| 65 | Arterial thrombosis (HP:0004420) | 2.04258668 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04223972 |
| 67 | Loss of speech (HP:0002371) | 2.03927538 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.03605569 |
| 69 | Lymphopenia (HP:0001888) | 2.03362323 |
| 70 | Hyporeflexia of lower limbs (HP:0002600) | 2.01310424 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.01051174 |
| 72 | Ankle contracture (HP:0006466) | 2.00220807 |
| 73 | Aortic dissection (HP:0002647) | 1.99707478 |
| 74 | Aneurysm (HP:0002617) | 1.99081269 |
| 75 | Myocardial infarction (HP:0001658) | 1.98551628 |
| 76 | Restrictive lung disease (HP:0002091) | 1.98308940 |
| 77 | Recurrent abscess formation (HP:0002722) | 1.98296088 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96520274 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95725322 |
| 80 | Osteolytic defects of the hand bones (HP:0009699) | 1.95725322 |
| 81 | Epistaxis (HP:0000421) | 1.94588923 |
| 82 | Viral hepatitis (HP:0006562) | 1.93892891 |
| 83 | Ventricular tachycardia (HP:0004756) | 1.93415269 |
| 84 | Radial bowing (HP:0002986) | 1.92162292 |
| 85 | Sepsis (HP:0100806) | 1.90538231 |
| 86 | Upper limb amyotrophy (HP:0009129) | 1.89556352 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 1.89556352 |
| 88 | Encephalitis (HP:0002383) | 1.89518353 |
| 89 | IgM deficiency (HP:0002850) | 1.89410681 |
| 90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89383810 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89362293 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89062561 |
| 93 | Frequent falls (HP:0002359) | 1.88544024 |
| 94 | Abnormality of T cell number (HP:0011839) | 1.88069979 |
| 95 | Abnormality of B cell number (HP:0010975) | 1.86874127 |
| 96 | Slow saccadic eye movements (HP:0000514) | 1.86094508 |
| 97 | IgA deficiency (HP:0002720) | 1.85767105 |
| 98 | Bundle branch block (HP:0011710) | 1.84384016 |
| 99 | Amyloidosis (HP:0011034) | 1.84144796 |
| 100 | Thoracic kyphosis (HP:0002942) | 1.83341659 |
| 101 | Recurrent sinusitis (HP:0011108) | 1.83256705 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 1.82979155 |
| 103 | Fatigue (HP:0012378) | 1.82790231 |
| 104 | Keratoconjunctivitis (HP:0001096) | 1.82582293 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 1.82343808 |
| 106 | Dysostosis multiplex (HP:0000943) | 1.81899004 |
| 107 | Micronodular cirrhosis (HP:0001413) | 1.81686061 |
| 108 | Pulmonary infiltrates (HP:0002113) | 1.81137518 |
| 109 | Recurrent bacterial skin infections (HP:0005406) | 1.80827453 |
| 110 | Urticaria (HP:0001025) | 1.80701227 |
| 111 | Verrucae (HP:0200043) | 1.80585566 |
| 112 | Papilloma (HP:0012740) | 1.80585566 |
| 113 | Cellulitis (HP:0100658) | 1.79771355 |
| 114 | T lymphocytopenia (HP:0005403) | 1.79629037 |
| 115 | Dislocated radial head (HP:0003083) | 1.79374965 |
| 116 | Ulnar bowing (HP:0003031) | 1.79295864 |
| 117 | Upper motor neuron abnormality (HP:0002127) | 1.78832014 |
| 118 | Bicuspid aortic valve (HP:0001647) | 1.76776085 |
| 119 | Colitis (HP:0002583) | 1.75769752 |
| 120 | Volvulus (HP:0002580) | 1.75488319 |
| 121 | Gastrointestinal carcinoma (HP:0002672) | 1.73374852 |
| 122 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.73374852 |
| 123 | 11 pairs of ribs (HP:0000878) | 1.72598693 |
| 124 | Dilatation of the ascending aorta (HP:0005111) | 1.72371628 |
| 125 | Amaurosis fugax (HP:0100576) | 1.71893486 |
| 126 | Severe short stature (HP:0003510) | 1.71884316 |
| 127 | Hypoplastic ischia (HP:0003175) | 1.71798804 |
| 128 | Missing ribs (HP:0000921) | 1.71605523 |
| 129 | Prominent nose (HP:0000448) | 1.70089716 |
| 130 | Emphysema (HP:0002097) | 1.68685091 |
| 131 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.68477981 |
| 132 | Vertebral compression fractures (HP:0002953) | 1.68139495 |
| 133 | Abnormality of the radial head (HP:0003995) | 1.68101594 |
| 134 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.67337531 |
| 135 | Myositis (HP:0100614) | 1.66671893 |
| 136 | Difficulty climbing stairs (HP:0003551) | 1.66132404 |
| 137 | Thoracolumbar scoliosis (HP:0002944) | 1.65271505 |
| 138 | Mediastinal lymphadenopathy (HP:0100721) | 1.62584687 |
| 139 | Increased connective tissue (HP:0009025) | 1.61981392 |
| 140 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.61851685 |
| 141 | Flat acetabular roof (HP:0003180) | 1.61646985 |
| 142 | Tubular atrophy (HP:0000092) | 1.61441541 |
| 143 | Cutaneous melanoma (HP:0012056) | 1.61287855 |
| 144 | Premature rupture of membranes (HP:0001788) | 1.60624878 |
| 145 | Abnormal foot bone ossification (HP:0010675) | 1.60571587 |
| 146 | Exostoses (HP:0100777) | 1.59826517 |
| 147 | Long eyelashes (HP:0000527) | 1.59070535 |
| 148 | Gastrointestinal inflammation (HP:0004386) | 1.58893491 |
| 149 | Periodontitis (HP:0000704) | 1.58305897 |
| 150 | Broad thumb (HP:0011304) | 1.58277661 |
| 151 | Vasculitis (HP:0002633) | 1.58222006 |
| 152 | Inflammation of the large intestine (HP:0002037) | 1.57430193 |
| 153 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.57404818 |
| 154 | Chest pain (HP:0100749) | 1.55993910 |
| 155 | Limited elbow extension (HP:0001377) | 1.55911613 |
| 156 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.55245973 |
| 157 | Type 1 muscle fiber predominance (HP:0003803) | 1.53921399 |
| 158 | Spondylolisthesis (HP:0003302) | 1.52595077 |
| 159 | Mitral valve prolapse (HP:0001634) | 1.52242587 |
| 160 | Osteomyelitis (HP:0002754) | 1.52066743 |
| 161 | Orchitis (HP:0100796) | 1.51378641 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.51162708 |
| 163 | Selective tooth agenesis (HP:0001592) | 1.50766616 |
| 164 | Truncal obesity (HP:0001956) | 1.50350718 |
| 165 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.49789755 |
| 166 | Short 4th metacarpal (HP:0010044) | 1.49789755 |
| 167 | Rectal prolapse (HP:0002035) | 1.49101465 |
| 168 | Wrist flexion contracture (HP:0001239) | 1.47697820 |
| 169 | Tibial bowing (HP:0002982) | 1.47630984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 2.88483816 |
| 2 | MAP3K10 | 2.82251896 |
| 3 | BLK | 2.77086863 |
| 4 | TTN | 2.71322053 |
| 5 | TRIB3 | 2.68321797 |
| 6 | PRPF4B | 2.51940043 |
| 7 | MAP3K14 | 2.40444420 |
| 8 | PKN2 | 2.39794754 |
| 9 | JAK3 | 2.33920488 |
| 10 | MAP4K1 | 2.21909614 |
| 11 | TYK2 | 2.21201548 |
| 12 | NEK2 | 2.10675803 |
| 13 | PTK6 | 2.04155454 |
| 14 | IRAK4 | 1.94236028 |
| 15 | EEF2K | 1.93436849 |
| 16 | PASK | 1.89946082 |
| 17 | STK10 | 1.82011081 |
| 18 | PRKD3 | 1.61219135 |
| 19 | TBK1 | 1.58024016 |
| 20 | FES | 1.54124323 |
| 21 | PDK3 | 1.54007925 |
| 22 | PDK4 | 1.54007925 |
| 23 | JAK1 | 1.53805051 |
| 24 | CHUK | 1.52987564 |
| 25 | ERN1 | 1.51076788 |
| 26 | RPS6KA4 | 1.50655426 |
| 27 | RIPK1 | 1.47965209 |
| 28 | STK3 | 1.45188863 |
| 29 | FLT3 | 1.43292379 |
| 30 | TESK1 | 1.42903655 |
| 31 | FRK | 1.37412265 |
| 32 | FGFR3 | 1.34094572 |
| 33 | FGFR4 | 1.33725810 |
| 34 | CDC7 | 1.31588716 |
| 35 | KSR2 | 1.31522041 |
| 36 | TEC | 1.29169281 |
| 37 | ZAP70 | 1.25314158 |
| 38 | FGR | 1.24810564 |
| 39 | LRRK2 | 1.24098173 |
| 40 | PDGFRA | 1.21456207 |
| 41 | LATS1 | 1.19957172 |
| 42 | SCYL2 | 1.17839547 |
| 43 | MARK2 | 1.17158994 |
| 44 | STK24 | 1.17014918 |
| 45 | CDK19 | 1.16062505 |
| 46 | IKBKB | 1.14737953 |
| 47 | TAOK3 | 1.14363050 |
| 48 | PIM1 | 1.14103265 |
| 49 | OBSCN | 1.13916477 |
| 50 | MAP3K7 | 1.13730277 |
| 51 | CDC42BPA | 1.12010080 |
| 52 | MAP3K13 | 1.07932574 |
| 53 | STK38L | 1.06865585 |
| 54 | TNK2 | 1.04083678 |
| 55 | CSK | 1.03164356 |
| 56 | CAMK1D | 1.00749602 |
| 57 | MTOR | 1.00173256 |
| 58 | IKBKE | 0.99603365 |
| 59 | MAPK7 | 0.96138161 |
| 60 | TGFBR1 | 0.96119113 |
| 61 | LYN | 0.95298160 |
| 62 | EPHA3 | 0.94732282 |
| 63 | PAK4 | 0.94693717 |
| 64 | CDK4 | 0.93267928 |
| 65 | CDK6 | 0.92594517 |
| 66 | MARK3 | 0.89619986 |
| 67 | MAP3K8 | 0.87957482 |
| 68 | MELK | 0.87370356 |
| 69 | DYRK1B | 0.86398329 |
| 70 | PDK1 | 0.86309837 |
| 71 | MAP3K3 | 0.85320226 |
| 72 | ICK | 0.84757560 |
| 73 | DMPK | 0.84506800 |
| 74 | SGK3 | 0.83091164 |
| 75 | BMX | 0.82750193 |
| 76 | GRK6 | 0.82296858 |
| 77 | NEK9 | 0.81833953 |
| 78 | MAPK12 | 0.79396973 |
| 79 | KIT | 0.78554141 |
| 80 | MAP2K3 | 0.78553637 |
| 81 | PDPK1 | 0.77578832 |
| 82 | MATK | 0.77447885 |
| 83 | SMG1 | 0.77307004 |
| 84 | RPS6KL1 | 0.77230458 |
| 85 | RPS6KC1 | 0.77230458 |
| 86 | STK4 | 0.77072923 |
| 87 | NEK1 | 0.76281864 |
| 88 | BTK | 0.75752844 |
| 89 | MAP3K1 | 0.75718155 |
| 90 | MAP3K6 | 0.75632025 |
| 91 | IRAK2 | 0.75533321 |
| 92 | CDK9 | 0.75260636 |
| 93 | PAK2 | 0.74429295 |
| 94 | IRAK3 | 0.73791796 |
| 95 | PDK2 | 0.73743165 |
| 96 | CAMK1G | 0.71485729 |
| 97 | WNK4 | 0.70046072 |
| 98 | ATR | 0.69621071 |
| 99 | IRAK1 | 0.68150436 |
| 100 | ITK | 0.67004861 |
| 101 | HIPK2 | 0.66205800 |
| 102 | BMPR2 | 0.66167360 |
| 103 | RET | 0.66124816 |
| 104 | SGK2 | 0.65564614 |
| 105 | EPHB1 | 0.65531315 |
| 106 | HCK | 0.64726442 |
| 107 | PTK2 | 0.64538447 |
| 108 | TGFBR2 | 0.63994128 |
| 109 | TAOK1 | 0.63483392 |
| 110 | RPS6KA6 | 0.63374019 |
| 111 | PRKAA2 | 0.63244523 |
| 112 | PDGFRB | 0.63188472 |
| 113 | MOS | 0.62840056 |
| 114 | RIPK4 | 0.62516391 |
| 115 | JAK2 | 0.62286901 |
| 116 | CSF1R | 0.62094917 |
| 117 | PRKD2 | 0.57014469 |
| 118 | PIK3CG | 0.56629735 |
| 119 | TTK | 0.56336960 |
| 120 | MAPK4 | 0.56266773 |
| 121 | MAPK11 | 0.55767041 |
| 122 | ACVR1B | 0.55475974 |
| 123 | NLK | 0.55325732 |
| 124 | CHEK1 | 0.54883615 |
| 125 | MYLK | 0.54523898 |
| 126 | LCK | 0.54140353 |
| 127 | BRD4 | 0.52265177 |
| 128 | YES1 | 0.51372139 |
| 129 | AURKB | 0.51340792 |
| 130 | CAMK4 | 0.50777797 |
| 131 | STK38 | 0.50081050 |
| 132 | TRPM7 | 0.48783410 |
| 133 | ALK | 0.45799930 |
| 134 | SYK | 0.44744167 |
| 135 | EPHA2 | 0.42855962 |
| 136 | ATM | 0.42798834 |
| 137 | RPS6KB2 | 0.42299266 |
| 138 | PTK2B | 0.41236028 |
| 139 | EGFR | 0.40676322 |
| 140 | NUAK1 | 0.39958805 |
| 141 | PIM2 | 0.39086618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13601687 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05986749 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93202259 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73034143 |
| 5 | Measles_Homo sapiens_hsa05162 | 1.69576140 |
| 6 | Asthma_Homo sapiens_hsa05310 | 1.67581379 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65320558 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65141825 |
| 9 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64492846 |
| 10 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.62966807 |
| 11 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56701567 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.49706900 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49058461 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 1.48515710 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46576987 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45678855 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43179880 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.41313852 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40994910 |
| 20 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.40721827 |
| 21 | Apoptosis_Homo sapiens_hsa04210 | 1.33614054 |
| 22 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.32083215 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.30750671 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28027679 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.27517680 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27102154 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.26680689 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26534509 |
| 29 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.26202604 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.25541772 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24591887 |
| 32 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20034435 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19348492 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19003259 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18709241 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.17586728 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17096587 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15248752 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14548844 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.14386796 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13328576 |
| 42 | Cell cycle_Homo sapiens_hsa04110 | 1.10395062 |
| 43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.08147437 |
| 44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07378580 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07220224 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 1.06107365 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04748248 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01959326 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.01372927 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.01339450 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00607552 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99037916 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97444649 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95922510 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93910393 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92131464 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92060293 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91599336 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91287124 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89760478 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.89270378 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87619252 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86864933 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86076315 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85931681 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85347542 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84406309 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84023534 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84016320 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.81920412 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81914544 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81875544 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80356799 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.79817321 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.79559396 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79539861 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.79296087 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.79133692 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78539043 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.78108772 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77583179 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77416822 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.77072661 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77044305 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76956126 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.76680441 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.76613819 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76393099 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75933820 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.73118812 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72018081 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71690067 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71284898 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71169214 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70129287 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68164706 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67748254 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67520904 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67359546 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66928877 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.66171505 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66064475 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65896075 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64830309 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64790110 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62944899 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62124536 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60208850 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60002105 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59677315 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58011468 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57809688 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56461193 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55625863 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.55170980 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55041188 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55026524 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54039523 |

